IL28B SNPs rs12979860 and rs8099917 Are Associated with Inflammatory Response in Argentine Chronic HCV Patients

ISSN Print: 2158-284X
ISSN Online: 2158-2882
www.scirp.net/journal/ijcm
E-mail: [email protected]

Citations

"IL28B SNPs rs12979860 and rs8099917 Are Associated with Inflammatory Response in Argentine Chronic HCV Patients"
written by Andrés Machicote, Diego Flichmann, Eloisa Arana, Silvia Paz, Hugo Fainboim, Leonardo Fainboim, Pablo M. Fernández,
published by International Journal of Clinical Medicine, Vol.9 No.2, 2018

has been cited by the following article(s):

[1]	Impacto de la ancestría genética en la distribución del polimorfismo de interferón-λ4 rs12979860 en una población global de Buenos Aires, Argentina
	BAG. Journal of basic and …, 2022

[2]	Impact of genetic ancestry on the distribution of interferon-λ4 RS12979860 polymorphism in a global population of Buenos Aires, Argentina= Impacto de la ancestría …
	2022

[3]	Development of a gene signature for predicting cirrhosis risk score of chronic liver disease associated with HCV infection in Egyptians
	2021

[4]	IMPACT OF GENETIC ANCESTRY ON THE DISTRIBUTION OF INTERFERON-λ4 RS12979860 POLYMORPHISM IN A GLOBAL POPULATION OF BUENOS …
	2021

[5]	Value of IFNL3 genetic polymorphism in the prediction of HCV treatment response to direct-acting antiviral drugs versus interferon therapy
	2020

[6]	Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients
	Genes & Diseases, 2019

[7]	Impact of genetic ancestry on the distribution of interferon-λ4 rs12979860 polymorphism in a global population of Buenos Aires, Argentina

[1]	IMPACT OF GENETIC ANCESTRY ON THE DISTRIBUTION OF INTERFERON-λ4 RS12979860 POLYMORPHISM IN A GLOBAL POPULATION OF BUENOS AIRES, ARGENTINA Journal of Basic and Applied Genetics, 2022 DOI:10.35407/bag.2022.33.02.02

[2]	Development of a gene signature for predicting cirrhosis risk score of chronic liver disease associated with HCV infection in Egyptians Microbial Pathogenesis, 2021 DOI:10.1016/j.micpath.2021.104805

[3]	Pharmacogenomics 2019 DOI:10.1016/B978-0-12-812626-4.00012-7

[4]	Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients Genes & Diseases, 2019 DOI:10.1016/j.gendis.2019.05.004